已收盘 01-09 16:00:00 美东时间
-3.720
-2.92%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Keefe, Bruyette & Woods analyst Damon Delmonte maintains Nicolet Bankshares (NYSE:NIC) with a Outperform and raises the price target from $160 to $165.
2025-12-18 02:10
为了推动医疗新质生产力发展,助力“健康中国2030”战略实施,第八届进博会医疗器械及医药保健展区以“健康中国,美好生活”为主题,汇聚全球顶尖医疗科技力量,呈现创...
2025-10-30 11:57
来源:划重点KeyPoints 作者林易 编辑重点君 10月29日,英伟达在华盛顿举行GTC大会,黄仁勋在演讲中...
2025-10-29 08:52
KFAR SAVA, Israel, Oct. 28, 2025 /PRNewswire/ -- Silicom Ltd. (NASDAQ: SILC), a leading provider of networking and data infrastructure solutions, today announced that an existing customer, a...
2025-10-28 20:30
来源:尺度商业 近年来,医美行业热度不减,医美材料及敷料领域涌现出巨子生物这样的明星上市公司,医美行业下游也出现了新的变化。 近日,港股上市公司美丽...
2025-10-26 17:05
NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholder...
2025-10-25 05:30
Nicolet Bankshares (NYSE:NIC) agreed to acquire MidWestOne Financial Group (NASDAQ:MOFG) in an all-stock deal that would create one of the largest community lenders in the Upper Midwest with over $15B...
2025-10-24 04:57
Nicolet Bankshares ( ($NIC) ) just unveiled an update. On October 23, 2025, Nic...
2025-10-24 04:53
Nicolet Bankshares (NYSE:NIC) reported quarterly earnings of $2.66 per share which beat the analyst consensus estimate of $2.34 by 13.53 percent. This is a 30.39 percent increase over earnings of $2.04 per share from the
2025-10-24 04:26